Teyi Pharmaceutical Group Co.,Ltd

SZSE:002728.SZ

17.38 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q1
Revenue 147.391163.051317.419206.912234.223304.157303.519197.912190.791194.348232.691167.234163.857194.379199.614132.981124.633175.467234.695208.408233.33244.689252.111218.614210.523203.727195.332167.345172.58151.687197.407158.552142.786157.111189.165142.29595.67989.40191.12580.18294.17979.26393.71778.24992.79677.959
Cost of Revenue 105.44291.712160.03293.255108.991113.061144.923102.461111.80192.648108.3185.33375.56386.87106.53970.70568.36181.48290.36288.23291.929103.98188.30191.35282.025102.16391.77491.28590.35682.32796.92983.95371.34690.507100.86481.86151.37448.56353.84748.06151.21739.27457.92442.19600
Gross Profit 41.94971.338157.387113.657125.232191.097158.59695.45178.99101.7124.38181.90188.294107.50993.07662.27556.27293.984144.333120.176141.401140.708163.81127.262128.498101.564103.55876.0682.22369.36100.47974.59971.4466.60388.30260.43444.30540.83837.27932.12142.96239.98835.79336.05392.79677.959
Gross Profit Ratio 0.2850.4380.4960.5490.5350.6280.5230.4820.4140.5230.5350.490.5390.5530.4660.4680.4520.5360.6150.5770.6060.5750.650.5820.610.4990.530.4550.4760.4570.5090.4710.50.4240.4670.4250.4630.4570.4090.4010.4560.5050.3820.46111
Reseach & Development Expenses 9.57711.1019.46712.5949.69510.18210.0889.939.3418.6511.2168.5839.3448.63410.5848.9648.6768.27612.3789.98210.96211.0619.51317.29110.459.37219.1137.86616.945053.338017.102028.44408.299017.98308.077016.283000
General & Administrative Expenses -10.02717.601-33.86741.129-10.31716.364-32.04736.711-8.53413.566-29.12535.446-7.43114.057-26.14514.643-6.96912.009-25.30613.44-5.80316.009-20.2913.445-12.39822.613-48.07219.951-11.52917.878-47.4522.834-11.07516.853-15.7215.205-1.7099.388-14.597.4917.3156.796-16.425.92600
Selling & Marketing Expenses 34.19336.07152.64141.10245.08335.53340.16530.76929.93716.52940.21922.27123.99832.24722.55923.16125.47427.72466.90946.98646.51945.1891.26329.74336.79442.27147.55318.46111.98525.01333.63519.97915.36420.70438.10718.17211.5946.49213.1259.4017.1046.26311.235.92300
SG&A 44.12252.13867.05182.23134.76651.8978.11867.4821.40330.09511.09357.71716.56846.304-3.58737.80318.50539.73441.60360.42640.71661.1970.97343.18824.39664.884-0.51938.4120.45642.891-13.81542.8144.28937.55722.38633.3789.88515.88-1.46516.89214.41913.059-5.1911.84900
Other Expenses -0.337-0.1190.004-4.1644.0322.23452.166-22.46919.2621.65-0.1410.206-0.226.6856.69-7.248-0.626-3.76-0.322-0.131-0.235-0.028-4.392-0.142-4.6714.455-0.4571.9479.7380.1092.7671.629.110.081.4471.878-3.0460.2-6.2931.328-0.0231.1-2.7760.601-68.86-51.997
Operating Expenses 53.69963.23976.51471.43970.61564.31370.37254.94150.00640.39569.29746.70746.37356.62749.90447.76548.07449.64499.19165.38570.69873.914118.37764.37958.15666.89975.43340.40338.01543.87873.28443.92338.32139.42367.34334.30123.6916.66423.51917.18215.52514.04517.89412.45-68.86-51.997
Operating Income -11.758.180.87340.70252.108127.04485.71637.47518.8254.53829.0328.47239.4343.63811.7878.0655.07833.29238.72248.38560.32650.14435.55554.12965.84426.37823.1830.86140.28821.62522.57426.93527.84323.08619.63524.34123.72124.07116.98918.73928.6325.94318.89524.47523.93625.962
Operating Income Ratio -0.080.050.2550.1970.2220.4180.2820.1890.0990.2810.1250.170.2410.2240.0590.0610.0410.190.1650.2320.2590.2050.1410.2480.3130.1290.1190.1840.2330.1430.1140.170.1950.1470.1040.1710.2480.2690.1860.2340.3040.3270.2020.3130.2580.333
Total Other Income Expenses Net 1.6523.094-7.582-0.08-0.052-0.019-0.11600.045-0.153-26.196-6.515-2.711-0.56-24.694-13.693-3.746-14.809-6.742-6.538-10.612-16.678-14.27-8.897-9.169-3.832-5.22-2.849-1.966-3.823-1.965-2.295-4.502-4.0140.0870.0853.1010.0973.5485.128-118.8911.0991.1850.872-0.0210.03
Income Before Tax -10.09811.19473.29140.62252.056127.02485.637.47518.86554.38528.88928.67839.2150.32318.4770.8174.45229.53238.448.25360.09150.11631.16453.98661.17330.83322.90632.80742.24221.65825.2328.38128.61823.16721.04526.21923.71624.27117.30920.06728.60727.04319.08524.47523.91525.992
Income Before Tax Ratio -0.0690.0690.2310.1960.2220.4180.2820.1890.0990.280.1240.1710.2390.2590.0930.0060.0360.1680.1640.2320.2580.2050.1240.2470.2910.1510.1170.1960.2450.1430.1280.1790.20.1470.1110.1840.2480.2710.190.250.3040.3410.2040.3130.2580.333
Income Tax Expense -3.6322.0398.5984.2655.40221.5545.1621.1713.0698.7184.8391.1245.5658.6533.432-0.564-0.0146.6080.9175.3388.9039.99-2.9838.34410.2116.038-2.0545.6766.7032.945-3.075.6544.8193.2162.2794.6223.6053.6411.4743.014.2914.0561.7553.6713.5873.899
Net Income -6.4659.15564.69436.35746.654105.47180.43836.30315.79645.66724.0527.55433.64541.6715.0451.3814.46722.92437.48342.91551.18740.12634.14745.64250.96224.79524.9627.13135.53918.71428.322.72723.79919.95118.76621.59720.11120.63115.83417.05724.31622.98617.3320.80320.32822.093
Net Income Ratio -0.0440.0560.2040.1760.1990.3470.2650.1830.0830.2350.1030.1650.2050.2140.0750.010.0360.1310.160.2060.2190.1640.1350.2090.2420.1220.1280.1620.2060.1230.1430.1430.1670.1270.0990.1520.210.2310.1740.2130.2580.290.1850.2660.2190.283
EPS -0.0130.0210.180.110.150.330.260.160.0690.20.120.130.160.140.110.0070.0210.0790.180.150.260.140.170.160.250.0860.130.10.170.0640.140.0790.120.0710.0960.0790.10.0710.0880.140.160.110.120.10.0970.11
EPS Diluted -0.0130.0210.180.110.150.310.260.160.0690.20.120.130.160.140.110.0070.0210.0790.180.150.260.140.170.160.250.0860.130.10.170.0640.140.0790.120.0710.0960.0790.10.0710.0880.140.160.110.120.10.0970.11
EBITDA 4.23411.04896.92745.35658.551128.24591.33343.1230.63561.79856.91236.22744.09964.19151.8937.78211.47750.58947.22158.02371.24266.74245.47264.21177.10734.29331.72536.12546.59225.63732.09730.0834.00727.59228.05527.05923.1625.70313.82313.397147.49826.32320.77623.60392.79677.959
EBITDA Ratio 0.0290.0680.3050.2190.250.4220.3010.2180.1610.3180.2450.2170.2690.330.260.0590.0920.2880.2010.2780.3050.2730.180.2940.3660.1680.1620.2160.270.1690.1630.190.2380.1760.1480.190.2420.2880.1520.1671.5660.3320.2220.30211